➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
AstraZeneca
Express Scripts
Johnson and Johnson
Colorcon

Last Updated: June 2, 2020

DrugPatentWatch Database Preview

LITHOTABS Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Lithotabs, and what generic alternatives are available?

Lithotabs is a drug marketed by Solvay and is included in one NDA.

The generic ingredient in LITHOTABS is lithium carbonate. There are fifteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the lithium carbonate profile page.

US ANDA Litigation and Generic Entry Outlook for Lithotabs

A generic version of LITHOTABS was approved as lithium carbonate by HIKMA on January 29th, 1982.

  Start Trial

Summary for LITHOTABS
Drug patent expirations by year for LITHOTABS
Synonyms for LITHOTABS
2BMD2GNA4V
554-13-2
ACMC-209lmw
AK00285039
AKOS015904647
ANGC-554-13-2
ANW-32310
B7705
C07964
Camcolit
Candamide
Carbolith
Carbolithium
Carbolithium IFI
Carbolitium
Carbonic Acid Dilithium Salt
Carbonic acid lithium salt
Carbonic acid lithium salt (Li2CO3)
Carbonic acid, dilithium salt
Carbonic acid, lithium salt
Carbonic acid, lithium salt (1:2)
CCRIS 3153
Ceglution
CHEBI:6504
CHEMBL1200826
CLi2O3
CP 15467-61
CP-15,467-61
CP-15467-61
CP-1546761
CTK1G9703
D00801
DB14509
Dilithium carbonate
Dilithium Carbonate, Dilithium Salt, Carbonic Acid
dilithium trioxidocarbonate
DTXSID1023784
EC 209-062-5
EINECS 209-062-5
Eskalith
Eskalith (TN)
Eskalith CR
Eutimin
FT-0627895
GK3300
HSDB 3351
Hypnorex
I494
KS-0000025D
KSC269O0H
L0224
Li2 (C O3)
Li2CO3
Limas
Liskonum
Litard
Lithane
Lithea
Lithicarb
Lithinate
Lithionate
LITHIUM CARBONATE
Lithium carbonate (2:1)
Lithium carbonate (JP17/USP)
Lithium carbonate (Li2CO3)
Lithium carbonate [USAN:JAN]
Lithium carbonate [USAN:USP:JAN]
Lithium Carbonate Nanoparticles
Lithium carbonate, 98+%, for analysis
Lithium carbonate, 99.999%, (trace metal basis), extra pure
Lithium carbonate, 99%, pure
Lithium carbonate, 99+%, ACS reagent
Lithium carbonicum
Lithium Phasal
Lithium QD
Lithium, Reference Standard Solution
Lithizine
Litho-Carb
Lithobid
Lithobid (TN)
Lithonate
Liticar
LS-88061
Manialith
Maniprex
MFCD00011084
Micalith
Neurolepsin
NSC-16895
Pfi-lithium
Pfl-Lithium
Phasal
Plenur
Priadel
Q410174
Quilonorm
Quilonum retard
RTR-019539
Teralithe
Teralithe [French]
TR-019539
TRA0065195
UNII-2BMD2GNA4V
XGZVUEUWXADBQD-UHFFFAOYSA-L

US Patents and Regulatory Information for LITHOTABS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Solvay LITHOTABS lithium carbonate TABLET;ORAL 016980-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
AstraZeneca
Express Scripts
Johnson and Johnson
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.